Delivery Order SPE2DB22D1017-SPE2DB25FE8NL

Award Date 11/5/24
Potential Completion Date 11/27/24
Potential Value $3.6K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a large pharmaceutical distributor, for the supply of COMIRNATY (Pfizer-BioNTech COVID-19 vaccine) syringes for individuals 12 years and older. The $13,505.70 firm fixed-price delivery order is part of a larger Indefinite Delivery Contract valued at up to $999,999,999 that Amerisourcebergen holds with DLA Troop Support Medical for providing a wide range of medical commodities to support...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, to provide COMIRNATY (Pfizer-BioNTech COVID-19 vaccine) syringes for individuals ages 12 and up. The $2,200.50 firm fixed-price delivery order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical division, which supplies a comprehensive range of pharmaceutical products and...
This federal contract award, valued at $2,220.84, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of COMIRNATY (Pfizer-BioNTech COVID-19 vaccine) syringes for individuals aged 12 and up, with a period of performance through January 10, 2025. This award is a delivery order under Amerisourcebergen's existing Indefinite Delivery Contract (IDC) with the DLA Troop...
This federal contract award is for the delivery of COMIRNATY (Pfizer-BioNTech COVID-19 vaccine) syringes to individuals aged 12 years and up. The award, valued at $1,467.00, was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is a delivery order under a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, for providing a comprehensive range of...
This federal contract award is for the delivery of COMIRNATY (Pfizer-BioNTech COVID-19 vaccine) syringes for individuals 12 years and older. The $7,335 firm-fixed-price delivery order was awarded to AmerisourceBergen Drug Corp by the Defense Logistics Agency (DLA), a defense agency, on October 18, 2024, with a completion date of November 8, 2024. The contract has no set-aside designation, indicating open competition. AmerisourceBergen, a major pharmaceutical distributor, is the prime...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $110,025.00 firm-fixed-price delivery order is for the supply of COMIRNATY (COVID-19 vaccine) syringes for individuals 12 years and older, with a completion date of September 26, 2024. The contract is not set-aside and is part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,667.50 firm fixed-price delivery order contract, with a completion date of November 20, 2024, is for the supply of COMIRNATY COVID-19 vaccine syringes for individuals aged 12 and above. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distribution company. The $73,350 firm-fixed-price delivery order is for the procurement of COMIRNATY (COVID-19) vaccine syringes for the 12 and up age group, with an ultimate completion date of November 18, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is for the delivery of COMIRNATY (COVID-19 vaccine) syringes for individuals aged 12 and up. The $1,480.58 firm fixed-price delivery order was awarded by the Defense Logistics Agency (DLA), a defense agency, and has a completion date of December 31, 2024. The contract does not have a set-aside designation, indicating open competition. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $7,335.00 firm-fixed-price delivery order is for the supply of COMIRNATY (COVID-19 vaccine) 0.3 mL syringes for recipients aged 12 and above. The contract has an ultimate completion date of November 19, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
  • SPE2DB22D1017
    Indefinite Delivery Contract
  • SPE2DB22D1017-SPE2DB25FE8NL
    Delivery Order

This federal contract award was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp. The $3,577.80 firm-fixed-price delivery order is for the supply of COMIRNATY (Pfizer-BioNTech COVID-19 vaccine) syringes for individuals aged 12 and up, with a completion date of November 27, 2024. Amerisourcebergen, a major pharmaceutical distributor, holds an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at $999,999,999 through November 2026, which serves as the primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract award did not specify any set-aside requirements, indicating open competition.

Generated 2/4/25, 10:19 AM